Picture of GVS logo

GVS — GVS News Story

0.000.00%
it flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: GVS H1 Adjusted EBITDA EUR 54.2 Mln

Aug 7 (Reuters) - GVS SpA GVS.MI:

H1 ADJUSTED EBITDA EUR 54.2 MILLION

IMPACT OF NEW TARIFFS IN THE FIRST HALF OF 2025 AMOUNTED TO APPROXIMATELY EURO 350,000

SEES THAT TARIFF IMPACT IN THE SECOND HALF OF 2025 IS EXPECTED TO BE ALMOST ENTIRELY OFFSET BY PRICE  INCREASES ALREADY IMPLEMENTED

SEES IN 2025 A LEVERAGE RATIO EXPECTED TO BE AROUND 2.2X AS OF 31 DECEMBER 2025, INCLUDING THE IMPACT OF THE ONGOING €20M BUYBACK

SEES IN 2025 MID-TO-HIGH SINGLE-DIGIT GROWTH IN CONSOLIDATED TURNOVER AT CONSTANT EXCHANGE RATES COMPARED TO FY2024, IN ACCELERATION IN H2 THANKS TO THE RAMP-UP OF WHOLE BLOOD REVENUES

SEES AN INCREASE IN THE ADJUSTED EBITDA MARGIN OF BETWEEN 150 AND 250 BASIS POINTS COMPARED TO 2024, INCLUDING THE TARIFF IMPACT

Further company coverage: GVS.MI

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on GVS

See all news